French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs)
- 浏览0
Hepatology
390A-390A页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



